Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)

China flag China · Delayed Price · Currency is CNY
17.02
+0.26 (1.55%)
Apr 28, 2026, 3:04 PM CST
28.45%
Market Cap 28.44B
Revenue (ttm) 6.01B
Net Income (ttm) -278.89M
Shares Out 1.67B
EPS (ttm) -0.17
PE Ratio n/a
Forward PE 19.23
Dividend 0.60 (3.58%)
Ex-Dividend Date Oct 22, 2025
Volume 30,680,569
Average Volume 15,494,647
Open 16.57
Previous Close 16.76
Day's Range 16.57 - 17.25
52-Week Range 13.12 - 21.58
Beta 0.61
RSI 54.69
Earnings Date Apr 28, 2026

About SHE:002603

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is base... [Read more]

Sector Healthcare
Founded 1992
Employees 11,708
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002603
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.